Seres Therapeutics, Inc. ($MCRB)
Henn Matthew R โ Chief Scientific Officer and EVP
Shares
238
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Henn Matthew R |
|---|---|
| Title | Chief Scientific Officer and EVP |
| Transaction Date | May 15, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 19, 2026 |
| Shares Purchased | 238 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 7,915 |
| Derivative | No |
| Accession Number | 0001193125-26-230727 |
| Document | View SEC Filing |